Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of NUDT19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 873.85 | 1445 / 1445 | 100% | 31.33 | 183 / 183 |
prostate | 100% | 902.20 | 245 / 245 | 100% | 44.23 | 501 / 502 |
uterus | 100% | 480.75 | 170 / 170 | 100% | 30.72 | 458 / 459 |
ovary | 100% | 460.89 | 180 / 180 | 100% | 27.95 | 429 / 430 |
breast | 100% | 683.14 | 459 / 459 | 100% | 34.83 | 1115 / 1118 |
bladder | 100% | 774.24 | 21 / 21 | 100% | 36.45 | 502 / 504 |
kidney | 100% | 659.64 | 89 / 89 | 100% | 18.68 | 897 / 901 |
skin | 100% | 1211.45 | 1809 / 1809 | 99% | 29.41 | 469 / 472 |
intestine | 100% | 713.98 | 966 / 966 | 99% | 34.00 | 523 / 527 |
pancreas | 100% | 509.11 | 328 / 328 | 99% | 18.87 | 176 / 178 |
thymus | 100% | 482.76 | 651 / 653 | 99% | 14.37 | 600 / 605 |
adrenal gland | 100% | 1617.49 | 258 / 258 | 99% | 24.59 | 227 / 230 |
lung | 99% | 679.67 | 574 / 578 | 99% | 33.95 | 1145 / 1155 |
stomach | 100% | 863.74 | 359 / 359 | 97% | 31.27 | 278 / 286 |
brain | 98% | 386.80 | 2585 / 2642 | 98% | 13.32 | 691 / 705 |
liver | 100% | 518.74 | 226 / 226 | 90% | 13.60 | 367 / 406 |
adipose | 100% | 666.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.51 | 29 / 29 |
muscle | 100% | 1661.72 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 759.51 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 24.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 37.56 | 1 / 1 |
blood vessel | 99% | 405.32 | 1317 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 778.27 | 838 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 14.19 | 74 / 80 |
peripheral blood | 73% | 564.01 | 681 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0036114 | Biological process | medium-chain fatty-acyl-CoA catabolic process |
GO_1902858 | Biological process | propionyl-CoA metabolic process |
GO_0044580 | Biological process | butyryl-CoA catabolic process |
GO_2001294 | Biological process | malonyl-CoA catabolic process |
GO_1901289 | Biological process | succinyl-CoA catabolic process |
GO_0008150 | Biological process | biological_process |
GO_0009062 | Biological process | fatty acid catabolic process |
GO_0015938 | Biological process | coenzyme A catabolic process |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0010945 | Molecular function | coenzyme A diphosphatase activity |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | NUDT19 |
Protein name | Acyl-coenzyme A diphosphatase NUDT19 (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 19) (Nudix motif 19) |
Synonyms | |
Description | FUNCTION: Fatty acyl-coenzyme A (CoA) diphosphatase that hydrolyzes fatty acyl-CoA to yield acyl-4'-phosphopantetheine and adenosine 3',5'-bisphosphate (By similarity). Mediates the hydrolysis of a wide range of CoA esters, including choloyl-CoA and branched-chain fatty-acyl-CoA esters and at low substrate concentrations medium and long-chain fatty-acyl-CoA esters are the primary substrates (By similarity). Highest activity seen with medium-chain acyl-CoA esters and higher rates of activity seen with the unsaturated acyl-CoA esters compared with the saturated esters (By similarity). Exhibits decapping activity towards dpCoA-capped RNAs in vitro (By similarity). . |
Accessions | A8MXV4 ENST00000397061.4 |